Phase II typically funds up to $1,000,000 to $1,500,000 for 24-36 months to continue the R&D effort from the completed Phase I project and work towards a prototype demonstration
Human equivalent ~5mg/kg/day using FDA allometric scaling
Melatonin synthesis and function: evolutionary history in animals and plants
Some patients may benefit from cycling the treatment (e.g., 5 days on, 2 days off) or adjusting injection timing for better results
DHLA has also been shown to reduce ascorbyl radicals produced during the oxidation of ascorbate by tocopheroxyl radicals [8]
The fifth, issued to Verony, was based on its manufacturing and distribution of oral GLP-1s that it falsely claimed were approved by FDA